Fujirebio Diagnostics Inc.
www.fujirebioamerica.com
Already a Biomedtracker subscriber?
You have access to the full company record through your subscription
Want to become a subscriber?
Subscribers get more company details, updates, company financials and company products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Fujirebio Diagnostics Inc.
Leqembi Set For Japan Launch After Twisty Pricing Process
Eisai/Biogen's Alzheimer's drug will be launched in Japan on 20 December with a lower price premium than Eisai was negotiating for after back-and-forth reimbursement negotiations, and strict use and monitoring restrictions.
Leqembi Set For Japan Launch After Twisty Pricing Process
Eisai/Biogen's Alzheimer's drug will be launched in Japan on 20 December with a lower price premium than Eisai was negotiating for after back-and-forth reimbursement negotiations, and strict use and monitoring restrictions.
Company Information
- Industry
- In Vitro Diagnostics
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Fujirebio Diagnostics Inc.
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice